These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10753199

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators.
    Anderson SP, Cattley RC, Corton JC.
    Mol Carcinog; 1999 Dec; 26(4):226-38. PubMed ID: 10569800
    [Abstract] [Full Text] [Related]

  • 3. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.
    Miller RT, Glover SE, Stewart WS, Corton JC, Popp JA, Cattley RC.
    Carcinogenesis; 1996 Jun; 17(6):1337-41. PubMed ID: 8681452
    [Abstract] [Full Text] [Related]

  • 4. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643.
    Rose ML, Cattley RC, Dunn C, Wong V, Li X, Thurman RG.
    Carcinogenesis; 1999 Nov; 20(11):2075-81. PubMed ID: 10545408
    [Abstract] [Full Text] [Related]

  • 5. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643.
    Marsman DS, Popp JA.
    Carcinogenesis; 1994 Jan; 15(1):111-7. PubMed ID: 7507413
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.
    Peters JM, Cattley RC, Gonzalez FJ.
    Carcinogenesis; 1997 Nov; 18(11):2029-33. PubMed ID: 9395198
    [Abstract] [Full Text] [Related]

  • 8. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
    Miller RT, Cattley RC, Marsman DS, Lyght O, Popp JA.
    Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS, Cattley RC, Conway JG, Popp JA.
    Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cloning genes responsive to a hepatocarcinogenic peroxisome proliferator chemical reveals novel targets of regulation.
    Corton JC, Moreno ES, Merritt A, Bocos C, Cattley RC.
    Cancer Lett; 1998 Dec 11; 134(1):61-71. PubMed ID: 10381131
    [Abstract] [Full Text] [Related]

  • 16. Role of thyroid hormones in hepatic effects of peroxisome proliferators.
    Miller RT, Scappino LA, Long SM, Corton JC.
    Toxicol Pathol; 2001 Dec 11; 29(1):149-55. PubMed ID: 11215679
    [Abstract] [Full Text] [Related]

  • 17. Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures.
    Karam WG, Ghanayem BI.
    Carcinogenesis; 1997 Nov 11; 18(11):2077-83. PubMed ID: 9395205
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.